ANGPTL4 and Caveolin-1 as potential novel biomarkers for metabolic syndrome in Iraqi adults over 50
References
- Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, et al. The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab 2023;35:414-428.e3. https://doi.org/10.1016/j.cmet.2023.02.003.
- Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome. Nat Rev Dis Prim 2024;10:60–77. https://doi.org/10.1038/s41572-024-00563-5.
- Nwankwo M, Okamkpa CJ, Danborno B. Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria. Diabetes Metab Syndr Clin Res Rev 2022;16:1–34.
- Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 2022;23:786.
- Liu L, Cai X-C, Sun X-Y, Zhou Y-Q, Jin M-Z, Wang J, et al. Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence. J Eur Acad Dermatol Venereol 2022;36:1969–79. https://doi.org/10.1111/jdv.18296.
- Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad Med J 2023;99:985–92. https://doi.org/10.1093/postmj/qgad008.
- Jamali Z, Ayoobi F, Jalali Z, Bidaki R, Lotfi MA, Esmaeili-Nadimi A, et al. Metabolic syndrome: a population-based study of prevalence and risk factors. Sci Rep 2024;14:3987. https://doi.org/10.1038/s41598-024-54367-4.
- Hung C-C, Zhen Y-Y, Niu S-W, Lin K-D, Lin HY-H, Lee J-J, et al. Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1-4 Patients. Biomedicines 2022;10:1–10. https://doi.org/10.3390/biomedicines10081858.
- Kharazmi-Khorassani S, Kharazmi-Khorassani J, Rastegar-Moghadam A, Samadi S, Ghazizadeh H, Tayefi M, et al. Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndrome. BMC Med Genet 2019;20:1–6. https://doi.org/10.1186/s12881-019-0825-8.
- Aryal B, Price NL, Suarez Y, Fernández-Hernando C. ANGPTL4 in Metabolic and Cardiovascular Disease. Trends Mol Med 2019;25:723–34. https://doi.org/10.1016/j.molmed.2019.05.010.
- Chen J, Luo Q, Yi Y, Wang J, Chen P, Luo F, et al. ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients. Lipids Health Dis 2024;23:1–9.
- Zuo Y, He Z, Chen Y, Dai L. Dual role of ANGPTL4 in inflammation. Inflamm Res Off J Eur Histamine Res Soc . [et Al] 2023;72:1303–13. https://doi.org/10.1007/s00011-023-01753-9.
- Abaj F, Saeedy SAG, Mirzaei K. Are caveolin-1 minor alleles more likely to be risk alleles in insulin resistance mechanisms in metabolic diseases? BMC Res Notes 2021;14:1–8.
- Peng H, Mu P, Li H, Lin S, Lin C, Lin K, et al. Caveolin-1 Is Essential for the Improvement of Insulin Sensitivity through AKT Activation during Glargine Treatment on Diabetic Mice. J Diabetes Res 2021;2021:1–9. https://doi.org/10.1155/2021/9943344.
- Mysling S, Kristensen KK, Larsson M, Kovrov O, Bensadouen A, Jørgensen TJD, et al. The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding. Elife 2016;5:1–9. https://doi.org/10.7554/eLife.20958.
- Estefes-Duarte JA, Espinosa-Sánchez A, Pérez-Hernández N, Ortiz MI, Fernández-Martínez E. Mechanisms of Bioactive Lipids to Modulate Master Regulators of Lipid Homeostasis and Inflammation in Metabolic Syndrome. Curr Pharm Biotechnol 2024;26:1755–76.
- Sylvers-Davie KL, Davies BSJ. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8. Am J Physiol Endocrinol Metab 2021;321:E493–508. https://doi.org/10.1152/ajpendo.00195.2021.
- Arefian M, Mazaheri-Tehrani S, Yazdi M, Kelishadi R. Caveolin Gene, a Possible Risk Factor for Metabolic Syndrome in Humans: A Systematic Review and Meta-Analysis. Int J Prev Med 2025;16:1–8.
- Boscher C, Nabi IR. Caveolin-1: role in cell signaling. Adv Exp Med Biol 2012;729:29–50. https://doi.org/10.1007/978-1-4614-1222-9_3.
- Simón L, Campos A, Leyton L, Quest AFG. Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer. Cancer Metastasis Rev 2020;39:435–53. https://doi.org/10.1007/s10555-020-09890-x.
- Yaikwawong M, Ek-eudomsuk P, Sittithumcharee G, Anupunpisit V, Peerapatdit T, Deerochanawong C, et al. A prevalent caveolin-1 gene rs926198 variant is associated with type 2 diabetes mellitus in the Thai population. Sci Rep 2024;14:1–9. https://doi.org/10.1038/s41598-024-78534-9.
- Baudrand R, Goodarzi MO, Vaidya A, Underwood PC, Williams JS, Jeunemaitre X, et al. A prevalent caveolin-1 gene variant is associated with the metabolic syndrome in Caucasians and Hispanics. Metabolism 2015;64:1674–81. https://doi.org/10.1016/j.metabol.2015.09.005.
- Fan K-C, Chen S-C, Yen I-W, Lin C-H, Kuo C-H, Lyu Y-P, et al. Plasma angiopoietin-like protein 4 as a novel biomarker predicting 10-year mortality in a community-based population: a longitudinal cohort study. Arch Med Sci 2025;21:51–9. https://doi.org/10.5114/aoms/189504.
- Gharipour M, Nezafati P, Sadeghian L, Eftekhari A, Rothenberg I, Jahanfar S. Precision medicine and metabolic syndrome. ARYA Atheroscler 2022;18:1–10. https://doi.org/10.22122/arya.2022.26215.
- Gesteiro E, Megía A, Guadalupe-Grau A, Fernandez-Veledo S, Vendrell J, González-Gross M. Early identification of metabolic syndrome risk: A review of reviews and proposal for defining pre-metabolic syndrome status. Nutr Metab Cardiovasc Dis 2021;31:2557–74. https://doi.org/ https://doi.org/10.1016/j.numecd.2021.05.022.
- Cho Y, Lee SY. Useful Biomarkers of Metabolic Syndrome. Int J Environ Res Public Health 2022;19. https://doi.org/10.3390/ijerph192215003.
- Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int J Med Sci 2016;13:25–38. https://doi.org/10.7150/ijms.13800.
- Pearson ER. Personalized medicine in diabetes: the role of ‘omics’ and biomarkers. Diabet Med 2016;33:712–7. https://doi.org/https://doi.org/10.1111/dme.13075.
- Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med 2024;30:1–21. https://doi.org/10.1186/s10020-024-01019-y.
- Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med 2021;42:199–214. https://doi.org/10.1055/a-1263-0898.
- de Souza GM, de Albuquerque Borborema ME, de Lucena TMC, da Silva Santos AF, de Lima BR, de Oliveira DC, et al. Caveolin-1 (CAV-1) up regulation in metabolic syndrome: all roads leading to the same end. Mol Biol Rep 2020;47:9245–50. https://doi.org/10.1007/s11033-020-05945-y.
- Rafaqat S, Sharif S, Majeed M, Naz S, Manzoor F, Rafaqat S. Biomarkers of Metabolic Syndrome: Role in Pathogenesis and Pathophysiology Of Atrial Fibrillation. J Atr Fibrillation 2021;14:1–9. https://doi.org/10.4022/jafib.20200495.
- Ilow R, Regulska-Ilow B, Różańska D, Kowalisko A, Biernat J. Prevalence of metabolic syndrome among 40- and 50-year-old inhabitants of Wroclaw, Poland. Ann Agric Environ Med 2012;19:551–6.
- Holmannova D, Borsky P, Andrys C, Kremlacek J, Fiala Z, Parova H, et al. The Influence of Metabolic Syndrome on Potential Aging Biomarkers in Participants with Metabolic Syndrome Compared to Healthy Controls. Biomedicines 2024;12:1–15. https://doi.org/10.3390/biomedicines12010242.
- Hooshmand E, Akbarzade I, Delbari D, Niroomand M, Ghavidel F, Saatchi M. Prevalence of Metabolic Syndrome Among Adults Aged 50 and Above and Associated Factors: A Cross-Sectional Study From Ardakan Cohort Study on Aging (ACSA). Heal Sci Reports 2025;8:1–7. https://doi.org/https://doi.org/10.1002/hsr2.70508.
Language: English
Page range: 98 - 104
Submitted on: Dec 18, 2025
Accepted on: Apr 6, 2026
Published on: Jul 3, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Haitham Ibrahim Azrak, Entedhar Rifaat Sarhat, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.